Charting the course across the blood-brain barrier

Por Nathanson, David, Mischel, Paul S.
Publicado em 2010

Biosafety and Biohazards: Understanding Biosafety Levels and Meeting Safety Requirements of a Biobank

Por Ta, Lisa, Gosa, Laura, Nathanson, David A.
Publicado no Biobanking (2018)

Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure

Por Nathanson, David, Frick, Mats, Ullman, Bengt, Nyström, Thomas
Publicado no Diabetol Metab Syndr (2016)

PET/CT in Oncology: Current Status and Perspectives

Por Czernin, Johannes, Allen-Auerbach, Martin, Nathanson, David, Herrmann, Ken
Publicado em 2013

Sex, Diastolic Blood Pressure, and Outcome after Thrombolysis for Ischemic Stroke

Por Nathanson, David, Patrone, Cesare, Nyström, Thomas, von Euler, Mia
Publicado em 2014

Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke

Por Darsalia, Vladimer, Larsson, Martin, Nathanson, David, Klein, Thomas, Nyström, Thomas, Patrone, Cesare
Publicado no J Cereb Blood Flow Metab (2015)

Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieu

Por Mansouri, Shiva, Lietzau, Grazyna, Lundberg, Mathias, Nathanson, David, Nyström, Thomas, Patrone, Cesare
Publicado no PLoS One (2016)

Safety of thrombolysis in stroke mimics: an observational cohort study from an urban teaching hospital in Sweden

Por Kostulas, Nikolaos, Larsson, Martin, Kall, Tor-Bjorn, von Euler, Mia, Nathanson, David
Publicado no BMJ Open (2017)

EXTH-67. TG02, A BRAIN-PENETRANT MULTI-CDK INHIBITOR, POTENTLY SUPPRESSES MYC-DRIVEN GLIOBLASTOMA

Por Tsang, Jonathan, Sung, Sarah, Gosa, Laura, Meetze, Kristan, Cloughesy, Timothy, Nathanson, David
Publicado no Neuro Oncol (2017)

GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals

Por Larsson, Martin, Patrone, Cesare, von Euler, Mia, Holst, Jens J., Nathanson, David
Publicado no Cardiovasc Diabetol (2019)

Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type...

Por Nyström, Thomas, Bodegard, Johan, Nathanson, David, Thuresson, Marcus, Norhammar, Anna, Eriksson, Jan W.
Publicado no Diabetes Obes Metab (2017)

Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study...

Por Norhammar, Anna, Bodegård, Johan, Nyström, Thomas, Thuresson, Marcus, Nathanson, David, Eriksson, Jan W.
Publicado no Diabetes Obes Metab (2019)

Sex-specific risks of death in patients hospitalized for hyponatremia: a population-based study

Por Mannheimer, Buster, Skov, Jakob, Falhammar, Henrik, Calissendorff, Jan, Lindh, Jonatan D., Nathanson, David
Publicado no Endocrine (2019)

Associations Between Antihypertensive Medications and Severe Hyponatremia: A Swedish Population–Based Case–Control Study

Por Falhammar, Henrik, Skov, Jakob, Calissendorff, Jan, Nathanson, David, Lindh, Jonatan D, Mannheimer, Buster
Publicado no J Clin Endocrinol Metab (2020)

Evaluation of the Genisys4, a Bench-Top Preclinical PET Scanner

Por Herrmann, Ken, Dahlbom, Magnus, Nathanson, David, Wei, Liu, Radu, Caius, Chatziioannou, Arion, Czernin, Johannes
Publicado em 2013

IMMU-20. CHARACTERIZING THE IMMUNE LANDSCAPE OF PD-1/PD-L1 IN BRAIN TUMOR IMMUNE CELL POPULATION USING CyTOF MASS CyTOMETRY

Por Lee, Alexander, Davidson, Tom, Galvez, Mildred, Nathanson, David, Wang, Anthony, Liau, Linda, Prins, Robert
Publicado no Neuro Oncol (2017)

CBMT-44. COMPREHENSIVE CHARACTERIZATION OF THE INTRINSIC APOPTOTIC MACHINERY REVEALS THE MOLECULAR BLOCKS RESPONSIBLE FOR RESISTANCE TO CELL DEATH IN GLIOBLASTOMA

Por Fernandez, Elizabeth, Mai, Wilson, Bayley, Nicholas, Liau, Linda, Cloughesy, Timothy, Letai, Anthony, Nathanson, David
Publicado no Neuro Oncol (2019)

TMIC-12 MODELING AND ESTIMATION OF TUMOR INTERSTITIAL FLUID PRESSURE AND NORMAL TISSUE COMPRESSION USING HYPERFOAM THEORY AND FINITE ELEMENT TECHNIQUE

Por Goudarzi, Narsollah, Faghihi, Reza, Ewing, James, Griffith, Brent, Nathanson, David, Arbab, Ali, Bagher-Ebadian, Hassan
Publicado no Neuro Oncol (2015)

Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014

Por Nathanson, David, Sabale, Ugne, Eriksson, Jan W., Nyström, Thomas, Norhammar, Anna, Olsson, Urban, Bodegård, Johan
Publicado no Pharmacoecon Open (2017)

Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide obse...

Por Norhammar, Anna, Bodegard, Johan, Nyström, Thomas, Thuresson, Marcus, Rikner, Klas, Nathanson, David, Eriksson, Jan W.
Publicado no Diabetes Obes Metab (2019)